Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
GlaxoSmithKline
GlaxoSmithKline
Eli Lilly and Company
University of Kentucky
Pfizer
National Institutes of Health Clinical Center (CC)
Hackensack Meridian Health
Dana-Farber Cancer Institute
BeiGene
Pfizer
Wake Forest University Health Sciences
Basilea Pharmaceutica
IntuiTap Medical, Inc
University of Virginia
Sumitomo Pharma America, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Novartis
TVAX Biomedical
Wake Forest University Health Sciences
TVAX Biomedical
University of Alabama at Birmingham
Bristol-Myers Squibb
Boston Scientific Corporation
University of Utah
Eli Lilly and Company
Proximagen, LLC
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Novartis
GlaxoSmithKline
Medical College of Wisconsin
Celgene
Novartis
University of California, San Francisco
University of California, San Francisco
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
University of Utah
AstraZeneca
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
University of South Florida
University of Utah
National Cancer Institute (NCI)
INSYS Therapeutics Inc